Aurora kinase inhibitors von Kitzen, J.J.E.M, de Jonge, M.J.A, Verweij, J

Volltext

Phase I dose-escalation study of F60008, a novel apoptosis inducer, in patients with advanced solid tumours von Kitzen, J.J.E.M, de Jonge, M.J.A, Lamers, C.H.J, Eskens, F.A.L.M, van der Biessen, D, van Doorn, L, ter Steeg, J, Brandely, M, Puozzo, Ch, Verweij, J

Volltext

Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours von de Jonge, M.J.A, Dumez, H, Kitzen, J.J.E.M, Beuselinck, B, Verweij, J, Courtney, R, Battista, A, Brega, N, Schöffski, P

Volltext

How to Define Treatment Success or Failure if Tumors Do Not Shrink: Consequences for Trial Design von Kitzen, J.J.E.M., Jonge, M.J.A. de, Verweij, J.

Volltext